Bader Bandar Alharbi¹*, Khalid Amer Almutairi², Ahmed Mohammed Alkanhal³ and Ibrahim Abdullah Aleisa³

¹Emergency Medicine Consultant, Emergency Department, Dr. Suliamanalhabib Group, Riyadh, Saudi Arabia
²Quality Improvement Specialist, Quality Management Department, Dr. Sulaiman Al Habib Medical Group, Riyadh, Saudi Arabia
³Radiology Specialist, Department of Radiology and Medical Imaging, Prince Sultan Military Medical City, Riyadh, Saudi Arabia

*Corresponding Author: Bader Bandar Alharbi, Emergency Medicine Consultant, Emergency Department, Dr. Suliamanalhabib Group, Riyadh, Saudi Arabia.

Received: May 05, 2025; Published: May 30, 2025

Abstract

Background: Healthcare systems invest in procedures that can help in addressing the disease management needs. Disease management must consider the inputs that would enable preventive and intervention-based processes in addressing the healthcare needs. The use of Artificial Intelligence (AI) focuses in the human-simulated intelligence that can be incorporated into healthcare. The aim of the review was to evaluate the application of AI in disease management in Saudi Arabia.

Methodology: The research used a systematic review approach, which focuses in critical appraisal of articles. The review used the PRISMA flowchart and the JBI checklists as the research tools to help in article selection. The review selected and used 13 articles that met the inclusion criteria set for the review.

Results: The findings indicated that the use of AI had direct implications in the management and actualization of the disease management in Saudi Arabia. AI enabled the management of diseases through addressing medication errors, issues with managing patient needs, information access and the overall actualization of the quality of the healthcare outcomes from the healthcare system. The implementation of AI would therefore help in building the required capacities and strategies that can generate the healthcare quality processes.

Conclusion: The use of the AI system can be used as part of the strategic measures for managing diseases in Saudi’s healthcare system. The aim would be to address the approaches and inputs that can help meet disease management needs, through the AI applications.

 Keywords: Artificial Intelligence; Disease Management; Healthcare Technology; Saudi Arabia; Health System Transformation; AI Adoption

References

1. Al-Jehani NB., et al. “Development of artificial intelligence techniques in Saudi Arabia: the impact on COVID-19 pandemic. Literature review”. Journal of Engineering Science and Technology (2021).
2. Alahmari N., et al. “A Data-Driven AI Approach and Tool to Co-Create Healthcare Services with a Case Study on Cancer Disease in Saudi Arabia”. Sustainability 6 (2022): 3313.
3. Ashehri R. “Governance of Artificial Intelligence in KSA (NEOM as a model)”. International Journal of Advanced Studies 1 (2019): 64-81.
4. Yu G., et al. “Improving chronic disease management for children with knowledge graphs and artificial intelligence”. Expert Systems with Applications 201 (2022): 117026.
5. Syed W and Al-Rawi MBA. “Community pharmacists awareness, perceptions, and opinions of artificial intelligence: A cross-sectional study in Riyadh, Saudi Arabia”. Technology Health Care1 (2024): 481-493.
6. Aboalshamat K., et al. “Medical and Dental Professionals Readiness for Artificial Intelligence for Saudi Arabia Vision 2030”. International Journal of Pharmaceutical Research and Allied Sciences 4 (2022): 52-59.
7. Siontis KC., et al. “Artificial intelligence-enhanced electrocardiography in cardiovascular disease management”. Nature Reviews Cardiology7 (2021): 465-478.
8. Alqudaihi KS., et al. “Cough Sound Detection and Diagnosis Using Artificial Intelligence Techniques: Challenges and Opportunities”. IEEE Access 9 (2021): 102327-10244.
9. Alghamdi SA and Alashban Y. “Knowledge, attitudes and practices towards artificial intelligence (AI) among radiologists in Saudi Arabia”. Journal of Radiation Research and Applied Sciences 2 (2023): 100569.
10. Rabaan AA., et al. “Application of Artificial Intelligence in Combating High Antimicrobial Resistance Rates”. Antibiotics 6 (2022): 784.
11. Almazroi AA., et al. “An empirical study of factors influencing e-health services adoption among public in Saudi Arabia”. Health Informatics2 (2022).
12. Chintala SK. “AI in public health: modelling disease spread and management strategies”. Neuro Quantology 8 (2022): 10830.
13. Nomura A., et al. “Artificial Intelligence in Current Diabetes Management and Prediction”. Current Diabetes Reports12 (2023): 61.
14. Alanzi T., et al. “Factors Affecting the Adoption of Artificial Intelligence-Enabled Virtual Assistants for Leukemia Self-Management”. Cureus (2023).
15. AlJarallah NA. “Investigating the influence of artificial intelligence on quality management in healthcare centers”. F1000 Research 12 (2023): 110.
16. Rajpurkar P., et al. “AI in health and medicine”. Nature Medicine1 (2023): 31-38.
17. Saeed A., et al. “Saudi Arabia Health Systems Challenging and Future Transformation With Artificial Intelligence”. Cureus (2023).
18. Al Kuwaiti A., et al. “A Review of the Role of Artificial Intelligence in Healthcare”. Journal of Personalized Medicine 6 (2023): 951.
19. Amann J., et al. “Explainability for artificial intelligence in healthcare: a multidisciplinary perspective”. BMC Medical Informatics and Decision Making1 (2020): 310.
20. Secinaro S., et al. “The role of artificial intelligence in healthcare: a structured literature review”. BMC Medical Informatics and Decision Making1 (2022): 125.
21. Chikhaoui E., et al. “Artificial Intelligence Applications in Healthcare Sector: Ethical and Legal Challenges”. Emerging Science Journal4 (2022): 717-738.

Citation

Citation: Bader Bandar Alharbi., et al. “Factors Influencing the Use of Artificial Intelligence in Disease Management in Saudi Arabia”.Acta Scientific Medical Sciences 9.6 (2025): 156-168.

Copyright

Copyright: © 2025 Bader Bandar Alharbi., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.